Summary. The effects of two unrelated diuretics, furosemido and amiloride on blood glucose, plasma insulin and glucose tolerance in the consCious rat are reported. Furosemide (1 mg/kg or 2 mg/kg) given intravenously caused an immediate but highly transient 23% and 53% fall in plasma insulin followed by a rise in blood glucose. The hyperglycaemic effect alone occurred in mild streptozotocin diabetic animals. Furosemide given with or 30 rain before intravenous glucose (0.5 G/kg) caused glucose intolerance with diminished insulin response. None of these effects were observed in adrenalectomised animals. Amiloride (1, 5 or 10 mg/kg) given I.V. alone immediately increased plasma insulin (up to 213 FU/ml) without affecting blood glucose. This effect was attenuated by mild streptozotocin diabetes. Amiloride given with or 30 min before glucose increased the insulin area without affecting glucose disappearance. Chronic administration enhanced glucose disappearance with increased plasma insulin re~aponsc, and caused hyperkalaemia. Chronic furosomide administration had no effects. Possible mechanisms for these effects are discussed.
In~oducfion
Glucose intolerance following diuretic therapy has been reported in man and in experimental animals, although the mechanism of the effect, its incidence and clinical importance remain controversial. Benzothiadiazine diuretics are known to exacerbate hyperglycaemia in diabetic patients (for review, see [1] ) and frequently to cause impaired carbohydrate tolerance in hypertensive patients [1] . Prospective studies in normal subjects [2] and non-diabetic hypertensive patients [3, 4] have shown that most patients who develop glucose intolerance have a diabetic predisposition, although prednisone-primed glucose tolerance tests or tolbutamide tests may reveal abnormalities in others [5, 6] . Animal studies have given conflicting results, showing hyperglycaemia [7, 8, 9] , impaired glucose tolerance [10] or no effect [11, 12] . Acute diuretic induced hyperglycaemia using large doses of diuretics under ether anaesthesia has been described in the rodent [13, 14, 15] , but few studies have examined sequential insulin changes in conscious animals. Further studies using small doses therefore seemed necessary, first to establish whether there was a consistent effect and second to examine the mechanisms involved.
Two 3iuretics were used, furosemide (Lasix) related to the benzothiadiazines, and amiloride (Midamor) a non-thiazide diuretic. Furosemide contains the thiazide * Presented in part at the 7th Annual meeting of the European Association for the study of diabetes, Southampton, 1971 . ** Wellcomo Junior Research Fellow.
sulphamoyl anthranilic acid structure, but the thiadiazinc ring is replaced by a furfuryl group (Fig. 1 ). It has been suggested that kaliuretic diuretics such as this may cause glucose intolerance secondary to potassium depletion, since potassium depletion is associated with diminished glucose tolerance [16] whilst repletion improves tolerance [17] . Amiloride is a pyrazine-carbonylguanidine which is structurally unrelated to the thiazides, has a weaker natriuretic effect and does not cause potassium loss [18] . The guanidine group of amiloride is shared by arginine, a potent stimulus to insulin secretion (Fig. 1) . It might there~fore be predicted that furosemide and amiloride would have opposite effects oil insulin secretion and glucose metabolism.
Results confirming this hypothesis are presented below.
Materials and Methods
Special Chemicals: Pttrc furosemide was a gift from Hoechst Pharmaceuticals, Ltd., and used at a final concentration of 1 and 2 mg/ml in normal saline, pH 7.0--7.4. Pure amiloride hydrochloride, a gift from Merck, Sharp and Dohme Ltd., was injected as a suspensionin normal saline at concentrations of I, 5 and 10 mg/ml. Anti-insulin serum was a gift from Dr. P.H. Wright; Ir'6-insulin was purchased from Abbott Laboratories, Chicago, U.S.A. Streptozotocin was kindly provided by the Upjohn Co., Kalamazoo, Michigan, U.S.A. Ultra pure water was obtained by pas.sing distilled water through an Elgaean ion exchange column (Elga Products Ltd., Lane End, Bucks).
A~mlytical methods:
Insulin was assayed by a micromodiiication of the double antibody radioimmunoassay of Soeldner and Slone [19] with ethylene diamine tetracetie acid (EDTA) present throughout the assay [20] . Purified rat insulin (kindly supplied by Novo Industri A/S Copenhagen) was used as the insulin standard. The assay was unaffected by furosemide and amiloride and allowed the measurement of I tzU insulin/ml in 50 ~zl plasma samples, derived from EDTA treated blood. Glucose was measured in a noutralised perehloric acid extract of whole blood by a glucose oxidase method [21] .
Sodium and potassium were measured by flame photometry using an E.E.L. integrating flame photometer with a lithium internal standard. Ammonium heparin plasma and red cell haemoly'sates were assayed after diluting 1: I00 with lithium working diluent. No correction was made for plasma trapping. Whole body sodium and p~tassium values were obtained by assaying the nitric acid digest of the minced carcas.
Animals:
Male white Wistar rats weighing 250 to 350 gm were used unless otherwise stated. Adrenaloctomised Wistar rats (Scientific Products Farm, Ash, Canterbury), maintained on 0.9~/o saline, were used 5--10 days after adrenaleetomy. Diabetic rats were obtained by intraporitoneal injection ~f 60 mg/kg or 75 mg/kg streptozotocin 48 h before the experiments.
Experimental model: Conscious overnight-starved rats were used 16--20 h after the insert, ion of small cannulae (0.4 mm internal diameter) into the left femoral artery and vein under light ether anaesthesia. The animals were kept in restraining cages with free access to water. Cannulae were kept patent with saline. Up to 0.35 ml arterial blood was withdrawn at each sample time, the volume being replaced with saline. Up to ten samples could be withdrawn witlmut changes in glucose or insulin.
Immediately on withdrawing, 100 ~zl of blood were added to 2 ml 2~) perchloric acid for subsequent glucose a~ay and the ~cmaining 0.2--0.25 ml were added to EDTA for insulin assay. Additional 0.4 ml blood samples were taken where applicable for plasma an(] red cell sodium and potassium assay.
Acute experimena~: The diuretics were given as acute IV boluses either alone, with, or thirty minutes before a standard glucose dose of 0.5 g/kg body weight. The latter was given intravenously as a 50~/o solution (w/v) in 15 see and subsequent timing of samples "*'as made from the end of the glucose infusion.
Chronic experiments: Groups of animals were given daily intraperitonoal injections of either furosomide 2 mg/ kg or 10 mg/kg amiloride. Control animals of similar weight were given an equivalent volume of intraperitoneal saline. After 30 days (furosemidc) and 10 days (amiloride) intravenous glucose tolerance tests were performed, 24 h after the last dose of diuretic.
Calculations:
The glucose disappearance rate (kg) was calculated using the absolute blood glucose values from 2.5-20 rain [22] . Insulin areas were calculated from the areas trader the insulin curves during the first five, ten, or hi thirty minutes of the test..~-~ ratios were calculated from the increments of plasma insulin add blood glucose values from the zero value [23] . Statistical significance was assessed by the Student 't' test.
Results

I. The effects of acute administration of furosemide on
blood glucose and plasma insulin a) Normal animals: A significant decrease in plasma insulin occurred with both 1 mg and 2 mg/kg furosemide ( Fig. 2 ; Table I ). Plasma insulin fell by 23%
.a_ 15o at I rain and 26% at 2.5rain with the lower dose (p. < 0.025), whereas with 2 mg/kg, there was a 53% decrease at one minute, the suppression persisting until 10 rain after injection, when the plasma insulin was still 30% (p < 0.05) below the fasting value. A small but significant rise in blood glucose occurred at twenty minutes with both groups and persisted to 30 min with 3* the higher dose. Absolute blood glucose and plasma insulin values showed some variation between groups. However, changes within groups were consistent. No significant changes in plasma insulin or blood glucose occurred in animals injected with saline alone. b) Diabetic animals: No significant change occurred in insulin secretion in the "mild" diabetic group after furosemide 2 mg/kg and although fasting values were within the normal range a sig~.cant rise in blood glucose of 27% occurred after 20 min (Table 1) . No change in blood glucose or plasma insulin occurred in the ketotic hyperglycaemic animals (Table 1) .
animals, animals given furoscmide 1 mg/kg and 2 rag/ kg simultaneously with glucose, and animals pretreated with furosemide 1 mg/kg 30 rain before glucose is shown in Fig. 3 . Control animals showed a glucose disappearance rate of 3.7 ' 0.27 ~ ( Table 2 ). Glucose disappearance was markedly decreased in the animals given furosemide either with or before glucose (Table 2) , although the 2.5 min blood glucose value in the low dose group and the 5 rain value in all the furosemide groups were significantly lower than in control animals ( Fig. 3) . However, the initial insulin response was 
II. The effects of acute administration of furosemide on
intravenous y~ucose tolerance a) Norma/animals: The response of blood glucose and plasma insulin to I.V. glucose (0.5 g/kg) in control much lower in the furosemide-treatcd animals ( Table  2 ). This was not significant in the pretreated group. AI values were also lower, particularly in the 2 mg/kg group confirming that the plasma insulin at the early times was inappropriately low for the plasma glucose ( Table 2 ). The thirty minute insulin area was decreased in all furosemide treated groups. b) Adrenalectamised animals: There was no significant difference ill any parameter between control adrenalectomised animals given glucose alone, and animals given glucose together with furosemide 2 rag/ kg (n -----3 for each group). Mean kg for control animals was 2.30% /rain and for the furosemide group 2.33%] min. Time: rain 
III. Cation changes after furosemide administration a) J~tring the glucose tolerance test: When furosemide
was given 30 rain before glucose, a significant fall in plasma and red cell potassium had occurred at the zero sample time. Red cell potassium had returned to control values at the end of the test, although plasma potassium was still decreased ( Table 3 ). The group receiving furosemide simultaneously with glucose showed no significant change. b) After chronic administration: There was no significant difference in plasma, red cell or total body cation values. Total body sodium was 100• 8 rag/ 100 G body weight compared with 123 -4-6 for controls, p : N.S. Total body potassium was 2PA• 17 rag/100 G body weight compared with 255 • 10 for controls, p: N.S.
IV. The effect8 of acute administration of amiloride on blood glucose and plasma insulin a) Normal animals:
Amiloride was injected as a suspension in normal s~line at 1 mg, 5 mg and 10 mg/kg (4, 20 and 40 ~M/kg respectively). A significant dose related increase in insulin secretion occurred one minute after injection in all groups, which persisted to 2.5 rain after injection in the high dose group (Fig. 4) (Table 4 ). There was marked attenuation of the absolute response compared with normal animals, but it represents a seventeen fold increase in plasma insulin compared with a nine fold increase in the normal group.
V. The effects of acute administration of amiloride on iutravenou~ glucose tolerance a) Normal animals:
The response of blood glucose and plasma insulin to I.V. glucose (0.5 g/kg) in control animals, animals given amiloride 5 mg/kg and 10 rag/ kg simultaneously with glucose, and animals pretreated with amiloride, 5 mg/kg, 30 rain before glucose is shown in Fig. 5 . Absolute blood glucose values in the amiloride treated groups were not significantly different from control values. Glucose disappearance rate was not affected. However, all the amiloride treated groups showed a highly significant increase in total 30 rain insulin area (Table 2) .
b) The effecta of chronic administration of amilorlde on intravenous gluc,~e tolerance: Intravenous glucose tolerance tests were performed after the daily intraperitoneal injection of amiloride 10 mg/kg for 10 days. Fasting blood glucose was significantly elevated in the experimental group with a slight elevation in plasma insulin (Fig. 6) . Glucose disappearance was markedly enhanced (kg 2.96 • 0.14 for controls, 4.16 4-0.17 for the amiloride treated group; p<0.005), and was associated with a significant elevation in peak initial in- Table 5 . In contrast with furosemide there is a higMy significant increase in plasma potassium in the experimental group (7.0 mEq/1 compared with 4.2 mEq/l p,~0.01), associated with increased total body potassium. chronically, could not show any effect. Foy and Furman [15] found hyperglycaemia, glucose intolerance and impaired insulin response in the mouse. Most of these studies can be criticized because of the use of very Mild diabetic animals received 60 mg/kg streptozotocin; moderate diabetic animals received 75 mg/kg streptozotocin.
Discussion
Previous studies in the rat have shown hyperglyeaemia and impaired glucose tolerance after acute administration of furosemide (50--200 mg/kg) [9, 14, 24] , while chronic administration (100 mg/kg/day) resulted in glucose intolerance [25] . In contrast, Senft et al. [12] using up to 200 mg/kg acutely or 200 mg/kg large doses and the use of anaesthesia, which in the rat is known to profoundly affect blood glucose and plasma insulin [26, 27, 28] . In addition, early sequential changes in insulin and glucose following diuretic administration have not been studied.
Our studies in the conscious rat have shown that low doses of furosemide suppress plasma insulin instantly with subsequent hyperglyeaemia. The rate of A. Aynsley-Green and K.O. Alberti: Diuretics and Carbohydrate Metabolism Diabetologia fall of plasma insulin is of particular interest in that the normal half-life of insulin quoted in the literature is of the order of 3--4.8 min [29] . Our data suggest a halflife of about one minute. This disappearance rate could have been artifically enhanced by an extremely rapid shift of fluid into the intravascular compartment.
-~ 2501 secretion since it persisted in diabetic animals without a change in plasma insulin. Possible hepaticmechanisms include catecholamine stimulation of glycogenolysis or inhibition of phosphodiesterase by furosemide, as suggested by Senft [12] . This hypothesis would explain the lack of effect on blood glucose in the ketotic hyperglycaemic animals in whom hepatic glycogen stores would be decreased. Decreased peripheral utilisation of glucose caused by furosemide has also been reported by Weller and Borondy [25] .
A change in glucose space is implied by the decreased absolute blood glucose values during the IVGTT with furosemide. A decreased glucose stimulus at the fl cell could then result in an apparent decrease in insulin secretion. However, the ~ ratio shows that the plasma j-f insulin response was still reduced.
Insulin release could have been suppressed by a direct effect on the pancreas, through an effect on electrolyte exchange which is of major importance in insulin release [30] . However, red cell and plasma sodium and potassium showed minimal changes in the present study, although this does not preclude effects on the fl cell which need not be reflected in changes in the plasma, nor be analagous to red cell effects.
The absence of any effect on glucose tolerance after chronic administration and the absence of significant changes in tissue cations supports the observation in man that chronic administration of furosemide does not affect glucose tolerance [3] .
In contrast, amiloride is a potent insulin secretagogue, with or without exogenous glucose. When given acutely alone, it caused a dose related increase in plasma insulin. Between 20 and 40 FtM/kg gave a similar peak insulin response to 2800 [zM/kg of glucose. The insulinogenic effect of a glucose load was potentiated both by the concurrent injection of amiloride, Adrenaleetomy abolishes the furosemide effects, im-and by pretreatment. Chronic administration of plying that in normal animals they are secondary amiloride also enhanced glucose stimulated insulin to catecholamine release. Foy and Furman [15] have, secretion. suggested this mechanism in the mouse. However, the Studies in man have given conflicting results on the hyperglycaemia is not due to a decrease in insulin effect of amiloride on blood glucose [31, 32, 33, 34, 35] without investigating its effect on plasma insulin. No effect on glucose tolerance was reported by PySr/~l/i and Rantanen [36] while McNay et al. [37] showed increased glucose disappearance and I/G ratios.
The lack of early changes in blood glucose suggests direct fl cell stimulation by amiloride. The diuretic promotes natriuresis and decreases potassium and hydrogen ion secretion by an effect on the renal tubule [18] . In frog skin [38] and toad bladder [39] amiloride inhibits sodium entry on the mucosal side of the cell. Inhibition of the sodium pump is not involved [18] .
A structural feature common to amiloride and other compounds affecting apical cell sodium transport in amphibia is the presence of a guanidine group, which has a close structural relationship to the triply hydrated sodium ion [40] . An effect of amiloride on active potassium [41] and sodium [34, 42] transport in the human red cell has also been described. It is possible that the action of amiloride reflects a direct effect on fl cell sodium and/or potassium exchange.
Other guanidine derivatives, including arginine, stimulate insulin secretion in vivo and in vitro [43, 44, 45, 46] . Amiloride shows similarities with arginine in that they both have synergistic effects with glucose, and both inhibit sodium transport in the toad bladder (Alberti, K.G.M.M. --unpublished observations). Thus it is possible that the stimulation of insulin secretion by all these compounds is due to the ionic effects of the guanidine group.
